CALMA Trial

POTOMAC, Md., June 10, 2026 IGC Pharma, Inc. (NYSE American: IGC) announced that its Phase 2 CALMA clinical trial...

POTOMAC, Maryland, April 28, 2026 IGC Pharma, Inc. has announced expanded caregiver engagement efforts as its Phase 2 CALMA...

POTOMAC, Md., Feb. 9, 2026 — IGC Pharma, Inc. announced the expansion of its ongoing Phase 2 CALMA clinical...